Showing results (1-10 of 1,133) with videos related to
Sort By:
Pageof 114
Current Drug Targets. Inflammation and Allergy|August 17, 2005
Osteoblasts and osteoclasts in bone remodeling and inflammationYoshiya Tanaka, Shingo Nakayamada, Yosuke OkadaThe Journal of Rheumatology|January 6, 2004
Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseasesShingo Nakayamada, Yosuke Okada, Kazuyoshi Saito, et al.The Journal of Biological Chemistry|September 5, 2003
Beta1 integrin/focal adhesion kinase-mediated signaling induces intercellular adhesion molecule 1 and receptor activator of nuclear factor kappaB ligand on osteoblasts and osteoclast maturationShingo Nakayamada, Yosuke Okada, Kazuyoshi Saito, et al.Journal of UOEH|March 28, 2020
Fulminant Type 1 Diabetes with Diversity in Peripheral Blood Lymphocytes: A Case ReportAkira Kurozumi, Yosuke Okada, Yusuke Miyazaki, et al.The Journal of Rheumatology|November 26, 2008
Alendronate protects premenopausal women from bone loss and fracture associated with high-dose glucocorticoid therapyYosuke Okada, Masao Nawata, Shingo Nakayamada, et al.Bone|April 15, 2019
IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2Akira Kurozumi, Kazuhisa Nakano, Kaoru Yamagata, et al.Expert Review of Clinical Immunology|September 1, 2021
Clinical relevance of T follicular helper cells in systemic lupus erythematosusShingo Nakayamada, Yoshiya TanakaBiomolecules|June 28, 2023
Immune Phenotype as a Biomarker for Systemic Lupus ErythematosusShingo Nakayamada, Yoshiya TanakaModern Rheumatology|August 19, 2022
Development of targeted therapies in IgG4-related diseaseShingo Nakayamada, Yoshiya TanakaInflammation and Regeneration|December 21, 2017
BAFF- and APRIL-targeted therapy in systemic autoimmune diseasesShingo Nakayamada, Yoshiya TanakaPageof 114